✦ LIBER ✦

Therapeutic outcome 3 years after switching of immunomodulatory therapies in patients with relapsing–remitting multiple sclerosis in Argentina

✍ Scribed by A. Carrá; P. Onaha; G. Luetic; M. Burgos; E. Crespo; N. Deri; M. Halfon; G. Jaacks; A. López; V. Sinay; C. Vrech

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of antibodies to i

✍ Klaus Bendtzen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Synergistic immunomodulatory effects of

✍ Frank Weber; Thomas Polak; Astrid Günther; Boris Kubuschok; Julia Janovskaja; An 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

Tau protein in cerebrospinal fluid: a po

✍ Antonio Martı́nez-Yélamos; Albert Saiz; Jordi Bas; Juan Jose Hernandez; Francesc 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Magnetic resonance imaging outcome of ne

✍ Andrea Paolillo; S. Bastianello; Marco Frontoni; Claudio Gasperini; Elisabetta G 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 58 KB

PRS28 COST-UTILITY ANALYSES OF DISEASE-M

✍ M Yang; WW Tseng; SS Sansgiry 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Effect of open label pulse cyclophospham

✍ Maria Ida Gobbini; Mary E Smith; Nancy D Richert; Joseph A Frank; Henry F McFarl 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 244 KB